Stephen Gibson, PharmD, Rph

Individuals with schizophrenia have experienced an increase in psychiatric, medical, and treatment risks because of the COVID-19 pandemic.

How can patient-centered, collaborative care help promote safety and stabilization in the treatment of patients with cooccurring diagnoses of schizophrenia and COVID-19?